Motoko Sasaki

18.0k total citations
238 papers, 8.8k citations indexed

About

Motoko Sasaki is a scholar working on Surgery, Hepatology and Molecular Biology. According to data from OpenAlex, Motoko Sasaki has authored 238 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Surgery, 82 papers in Hepatology and 72 papers in Molecular Biology. Recurrent topics in Motoko Sasaki's work include Cholangiocarcinoma and Gallbladder Cancer Studies (98 papers), Pediatric Hepatobiliary Diseases and Treatments (59 papers) and Liver Diseases and Immunity (51 papers). Motoko Sasaki is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (98 papers), Pediatric Hepatobiliary Diseases and Treatments (59 papers) and Liver Diseases and Immunity (51 papers). Motoko Sasaki collaborates with scholars based in Japan, United States and Taiwan. Motoko Sasaki's co-authors include Yasuni Nakanuma, Yasunori Sato, Kenichi Harada, Yasuni Nakanuma, Yoh Zen, Hiroko Ikeda, Koichi Tsuneyama, Hiroko Ikeda, Masami Miyakoshi and Junpei Yamaguchi and has published in prestigious journals such as Cell, PLoS ONE and Hepatology.

In The Last Decade

Motoko Sasaki

234 papers receiving 8.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Motoko Sasaki Japan 52 5.0k 2.5k 2.2k 2.1k 2.0k 238 8.8k
Kenichi Harada Japan 51 4.9k 1.0× 1.8k 0.7× 1.9k 0.8× 3.3k 1.6× 3.2k 1.6× 334 9.6k
Monique Fabrè France 45 2.7k 0.5× 2.8k 1.1× 2.3k 1.0× 1.9k 0.9× 2.1k 1.0× 239 8.1k
Louis Libbrecht Belgium 48 2.3k 0.5× 2.1k 0.8× 2.0k 0.9× 2.1k 1.0× 3.5k 1.7× 170 7.5k
Hans Peter Dienes Germany 48 2.1k 0.4× 1.8k 0.7× 1.4k 0.6× 2.4k 1.2× 2.3k 1.1× 130 6.9k
Charles Balabaud France 55 3.4k 0.7× 4.7k 1.9× 2.4k 1.1× 3.5k 1.7× 5.6k 2.7× 238 12.5k
Steven Dooley Germany 53 1.6k 0.3× 4.5k 1.8× 1.7k 0.8× 3.0k 1.5× 3.7k 1.8× 237 10.2k
Jiro Fujimoto Japan 39 2.2k 0.4× 2.1k 0.8× 1.5k 0.7× 1.5k 0.7× 2.6k 1.3× 185 7.1k
Grant A. Ramm Australia 46 1.5k 0.3× 1.3k 0.5× 1.1k 0.5× 1.6k 0.8× 1.6k 0.8× 181 6.9k
Pieter Demetter Belgium 43 1.2k 0.2× 1.8k 0.7× 2.5k 1.1× 993 0.5× 480 0.2× 199 6.4k
Lopa Mishra United States 49 1.4k 0.3× 3.8k 1.5× 2.7k 1.2× 798 0.4× 1.1k 0.5× 169 7.8k

Countries citing papers authored by Motoko Sasaki

Since Specialization
Citations

This map shows the geographic impact of Motoko Sasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoko Sasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoko Sasaki more than expected).

Fields of papers citing papers by Motoko Sasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motoko Sasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoko Sasaki. The network helps show where Motoko Sasaki may publish in the future.

Co-authorship network of co-authors of Motoko Sasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Motoko Sasaki. A scholar is included among the top collaborators of Motoko Sasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motoko Sasaki. Motoko Sasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasaki, Motoko, Yasunori Sato, & Yasuni Nakanuma. (2024). Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(6). 915–923. 3 indexed citations
2.
Sasaki, Motoko, Yasunori Sato, & Yasuni Nakanuma. (2024). A heterogeneous subtype of biliary epithelial senescence may be involved in the pathogenesis of primary biliary cholangitis. Clinics and Research in Hepatology and Gastroenterology. 49(1). 102512–102512. 3 indexed citations
3.
Nakanuma, Yasuni, Yasunori Sato, Motoko Sasaki, et al.. (2024). A Pathological Assessment of the Microvasculature of Biliary Tract Neoplasms Referring to Pre-Existing Blood Vessels and Vessel Co-Option. Cancers. 16(22). 3869–3869. 2 indexed citations
4.
Kim, Soo Ryang, Soo Ki Kim, Hisato Kobayashi, et al.. (2024). Acetaminophen-induced liver injury with atypical histopathologic findings: a case report. Kanzo. 65(2). 74–80.
5.
Kim, Soo Ryang, Soo Ryang Kim, Soo Ki Kim, et al.. (2023). Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity. Diagnostics. 13(17). 2857–2857. 5 indexed citations
6.
Sasaki, Motoko, Yasunori Sato, & Yasuni Nakanuma. (2023). An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis. Clinics and Research in Hepatology and Gastroenterology. 47(4). 102106–102106. 3 indexed citations
7.
Sasaki, Motoko, Yasuo Satô, & Yasuni Nakanuma. (2022). Is nestin a diagnostic marker for combined hepatocellular–cholangiocarcinoma?. Histopathology. 80(5). 859–868. 14 indexed citations
8.
Sasaki, Motoko & Yasunori Sato. (2021). An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(4). 697–703. 6 indexed citations
9.
Sato, Yasunori, Shogo Tanaka, Masahiko Kinoshita, et al.. (2020). Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy. Journal of Hepato-Biliary-Pancreatic Sciences. 27(11). 860–869. 14 indexed citations
10.
Sasaki, Motoko, Yasunori Sato, & Yasuni Nakanuma. (2020). Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma. Histopathology. 78(2). 310–320. 13 indexed citations
11.
Sasaki, Motoko, Fang‐Ying Kuo, Chao‐Cheng Huang, et al.. (2018). Increased expression of senescence‐associated cell cycle regulators in the progression of biliary atresia: an immunohistochemical study. Histopathology. 72(7). 1164–1171. 12 indexed citations
12.
Honda, Masao, Akihiro Tanaka, Yoshimoto Nomura, et al.. (2013). Association of Interleukin-28B Genotype and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C. Clinical Cancer Research. 19(7). 1827–1837. 55 indexed citations
13.
Kitao, Azusa, Yasunori Sato, Seiko Sawada‐Kitamura, et al.. (2009). Endothelial to Mesenchymal Transition via Transforming Growth Factor-β1/Smad Activation Is Associated with Portal Venous Stenosis in Idiopathic Portal Hypertension. American Journal Of Pathology. 175(2). 616–626. 66 indexed citations
14.
Sakurai, Masaru, Toshinari Takamura, Tsuguhito Ota, et al.. (2007). Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. Journal of Gastroenterology. 42(4). 312–317. 39 indexed citations
15.
Itatsu, Keita, Takahiko Fujii, Motoko Sasaki, Yoh Zen, & Yasuni Nakanuma. (2007). Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma.. PubMed. 54(75). 677–80. 9 indexed citations
16.
Sasaki, Motoko, Yoh Watanabe, Wilson M. S. Tsui, et al.. (2001). Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis. Histopathology. 38(6). 550–560. 30 indexed citations
17.
Iwata, Mitsuhiro, Mitsuhiro Iwata, Motoko Sasaki, et al.. (2001). Intrahepatic Cholangitis and Arteritis after Transcatheter Arterial Embolization in a Patient with Tumor-like Lesion-associated Autoimmune Hepatitis. Pathology - Research and Practice. 197(1). 59–64. 1 indexed citations
18.
19.
20.
Sasaki, Motoko, et al.. (1982). Lithium influence on the circadian rhythms of normal adults. 40. 303–308. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Harada Breakdown of academic impact, for papers by Monique Fabrè Breakdown of academic impact, for papers by Louis Libbrecht Breakdown of academic impact, for papers by Hans Peter Dienes Breakdown of academic impact, for papers by Charles Balabaud Breakdown of academic impact, for papers by Steven Dooley Breakdown of academic impact, for papers by Jiro Fujimoto Breakdown of academic impact, for papers by Grant A. Ramm Breakdown of academic impact, for papers by Pieter Demetter Breakdown of academic impact, for papers by Lopa Mishra
Rankless by CCL
2026